We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
BGT.AU

Price
0.04
Stock movement up
+- (%)
Company name
Bio-Gene Technology Ltd
Exchange
(AU
,
Currency
AUD
)
Sector
Healthcare >
Biotechnology
Market cap
7.25M
Ent value
5.41M
Price/Sales
28.19
Price/Book
2.60
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-4.42%
1 year return
-44.62%
3 year return
-45.71%
5 year return
-29.03%
10 year return
-
Last updated: 2025-04-05

DIVIDENDS

BGT.AU does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales28.19
Price to Book2.60
EV to Sales21.03

FINANCIALS

Per share

Loading...
Per share data
Current share count201.36M
EPS (TTM)-0.03
FCF per share (TTM)-0.03

Income statement

Loading...
Income statement data
Revenue (TTM)257.18K
Gross profit (TTM)-465.49K
Operating income (TTM)-6.69M
Net income (TTM)-5.50M
EPS (TTM)-0.03
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-181.00%
Operating margin (TTM)-2601.39%
Profit margin (TTM)-2140.49%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash2.21M
Net receivables523.96K
Total current assets2.94M
Goodwill0.00
Intangible assets203.19K
Property, plant and equipment56.24K
Total assets3.16M
Accounts payable47.24K
Short/Current long term debt0.00
Total current liabilities345.93K
Total liabilities368.45K
Shareholder's equity2.79M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-6.03M
Capital expenditures (TTM)5.70K
Free cash flow (TTM)-6.04M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-197.23%
Return on Assets-174.23%
Return on Invested Capital-197.23%
Cash Return on Invested Capital-216.27%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.04
Daily high0.04
Daily low0.04
Daily Volume0K
All-time high0.34
1y analyst estimate0.37
Beta0.70
EPS (TTM)-0.03
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
BGT.AUS&P500
Current price drop from All-time high-89.41%-17.56%
Highest price drop-91.76%-56.47%
Date of highest drop24 Jan 20259 Mar 2009
Avg drop from high-53.96%-11.07%
Avg time to new high218 days12 days
Max time to new high995 days1805 days
COMPANY DETAILS
BGT.AU (Bio-Gene Technology Ltd) company logo
Marketcap
7.25M
Marketcap category
Small-cap
Description
Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; Qcide, a natural plant-derived oil with high levels of tasmanone. The company has a research collaboration agreement with James Cook University to support research and field operations relating to processing and distillation of oil from biomass; AgriFor Scientific, a chemistry product; cesar for assessing the insecticidal activity of molecules against a various insect species; CSIRO, a chemistry development process; Department of Agriculture and Fisheries, Queensland Government for assessing activity against grain storage pests; Eurofins; Grain Research Development Corporation; Pacific Discovery Services; Purdue University; Southern Cross University, a chemical analysis of natural products; University of Florida; and University of Technology. It serves animal health, crop protection, grain storage, public health, and consumer applications. The company was incorporated in 1995 and is based in Melbourne, Australia.
Employees
0
Investor relations
-
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found